Open AccessLevosulpiride Increases the Levels of Prolactin and Antiangiogenic Vasoinhibin in the Vitreous of Patients with Proliferative Diabetic Retinopathy
Author(s) -
Carlos D. NúñezAmaro,
Aura MorenoVega,
Elva AdánCastro,
Magdalena Zamora,
Renata García-Franco,
Paulina Ramírez-Neria,
Marlon García-Roa,
Yolanda Villalpando,
Juan Pablo Robles,
Gabriela RamírezHernández,
Mariana López,
Jorge Sánchez,
Ellery López-Star,
Thomas Bertsch,
Gonzalo Martı́nez de la Escalera,
Ludivina RoblesOsorio,
Jakob Triebel,
Carmen Clapp
Publication year - 2020
Publication title -
translational vision science and technology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.508
H-Index - 21
ISSN - 2164-2591
DOI - 10.1167/tvst.9.9.27
Subject(s) - diabetic retinopathy , vitrectomy , medicine , endocrinology , prolactin , macular hole , diabetes mellitus , retinal , vascular endothelial growth factor , retinopathy , ophthalmology , hormone , visual acuity , vegf receptors
These findings support the potential therapeutic benefit of levosulpiride against vision loss in diabetes.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom